AstraZeneca and Vodafone enter partnership to improve cardiovascular health

By Admin
The recent announcement of a global partnership between Vodafone and the UKs AstraZeneca is bent on assisting patients with serious cardiovascular condi...

The recent announcement of a global partnership between Vodafone and the UK’s AstraZeneca is bent on assisting patients with serious cardiovascular conditions. This relationship will work with various healthcare professionals using mobile technology to increase patient communication capabilities: both mHealth and internet-based mHealth services.

Taking lead on the project, AstraZeneca’s Intelligent Pharmaceutical Group will spearhead the project’s management and development components, with Vodafone’s technology, infrastructure and expertise as the backbone behind its ideas.

Vodafone’s Director for its Machine to Machine program stated, “Bringing together the best in connectivity with the best in treatment and education will create powerful and compelling outcomes for patients. AstraZeneca is a global leader in the mHealth field and we are delighted to work with them to develop these innovative services.”

Share

Featured Articles

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Three months on, the cyberattack on UnitedHealth Group's Change Healthcare is still affecting US citizens, with delays and

McKinsey: National E-health Initiatives on the Rise

McKinsey report on countries that are scaling national e-health programmes says it is easing financial pressures on healthcare systems globally

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma

London Hospitals Cyberattack Wreaks Healthcare Havoc

Technology & AI

Healthcare Provision in India: Challenges and Opportunities

Health Insurance & Finance